Potential downside breakout for biotech. Still too early to confirm whether it's real or a fake, keep an eye on this one. Entered 25% position so far, will look to add more if further confirmation appears.
UnitedHealth is making a bullish trend line breakout in the first hour of trading. After blowout earnings and a guidance revision, UNH is a great value at this price. I intend to hold this for a while.
Last week, SELECT MEDICAL HOLDINGS CORP - NYSE:SEM recaptured its 200 DMA and now finds itself attempting to build on the recent grind into higher ground. In addition, when we examine the action of the Daily chart above, we can also observe that SEM appears to be coming out of a potential rounding bottom. Furthermore, the stock now finds itself trading above...
RAD has been profiting of Amazon using it's stores. Which is basically saving the company. RAD is finding support again around $6.4, not getting to oversold levels! (RSI(10) < 30) Be mindful that today's volume is below the average volume (which is a bearish sign on a pullback). Important to check today's price & volume at close.
After strong earnings and a guidance upgrade, I've just been waiting for an entry point on UNH . Today we are oversold on the hourly RSI and stochastic , and I'm seeing a little bullish divergence coming in on the hourly MACD histogram. We've got support at 254.44 from the 20-day moving average, though there's not a lot of volume located here on the volume...
Merck ended the day near the bottom of its parallel channel, right above a high-volume support node at 8.19 and a trend line that's parallel with channel bottom. After hours, the price has moved below both the support and the trend line, but in my experience, after hours moves don't necessarily mean much. The real test will be tomorrow after market open. If the...
It's not every day you see a stock get this oversold on its weekly chart. Mednax, Inc. has lost about 50% of its value over the past year due to some earnings and revenue misses and year-over-year declines. After this drop, Mednax has a very attractive P/E of 8.66. Its forward P/E of 6.84 indicates that its earnings are expected to grow. S&P Capital IQ rates the...
HQY Not a major headline grabber, but growth is excellent. Now the chart has opened up technically for a run to 90+ without too much static. I am accumulating here, just a few options, but holding bigger buys for a pullback/reset to 72's for a bigger load up. The Aug 16 C90 is currently sitting at .50, and premium would significantly drop on any pullback. Load...
TDOC with great technicals. RSI(10) @60 reaching higher OBV on higher highs ADX(14) @24 DI+ > DI -
EPISODE 4/11: US HEALTH CARE(XLV) SECTOR Technical Analysis - 16th of July 2019. There is really not much to say. Profits in the health care sector are very reliable on the cycle. Since Trump took office, the cycle extended, and hence it formed a channel as noted in the analysis. One major risk that has always affected the health care sector is regulation and...
WELL (WELL Health Technologies Corp) is one of the hottest stocks of July as it has grown so far by 77% on a monthly basis making a jump of +175% since the beginning of June. Currently this is no time to enter this frenzy as past price action has shown that after a +170% rise and overbought levels on the 1D chart, consolidation follows and then a test of the 4H...
study charts high trade robinhood high buy pot stocks low get high ROI
UNH is looking like a great buy. Not only did it break out today above a downward trendline, but it's also near the bottom of an upward-sloping parallel channel. Fundamentals look good too, with generally positive analyst ratings and a series of recent earnings beats. Healthcare is hot right now, with its low China exposure and other sectors looking overbought....
CERN has been forming a triangle as it decides between two different parallel channels. I expect the longer-term upward channel to prevail on the strength of impressive analyst ratings and the overall strength of the healthcare sector. Look for an entry below 71.63 in the next week, with stops below the triangle.
Although this seems to be a risky long trade. The reward is looking promising. Looking at the fundamentals, this company is well positioned with Cash. Debt is manageable even though the company is burning through cash (but that what most healthcare companies do until their products get FDA approval). Targets and Stops are in the graphic.
Since breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above. With the stock trading...
Last week, ENZO BIOCHEM INC - NYSE:ENZ broke to higher ground and in the process, recaptured its 200 DMA out of a rounding bottom and now finds itself digesting/consolidating the move within a Flag pattern on lower volume as is evidenced in the Daily chart above. In addition, ENZ is now trading above all of its important moving averages 20/50/200 DMA's and...